JP2005120094A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005120094A5 JP2005120094A5 JP2004304559A JP2004304559A JP2005120094A5 JP 2005120094 A5 JP2005120094 A5 JP 2005120094A5 JP 2004304559 A JP2004304559 A JP 2004304559A JP 2004304559 A JP2004304559 A JP 2004304559A JP 2005120094 A5 JP2005120094 A5 JP 2005120094A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- ala
- tyr
- bone
- leu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000988 bone and bone Anatomy 0.000 claims 9
- 241000124008 Mammalia Species 0.000 claims 8
- 239000013543 active substance Substances 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- NILQLFBWTXNUOE-UHFFFAOYSA-N 1-aminocyclopentanecarboxylic acid Chemical compound OC(=O)C1(N)CCCC1 NILQLFBWTXNUOE-UHFFFAOYSA-N 0.000 claims 2
- 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 claims 2
- 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 claims 2
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 claims 2
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 claims 2
- 240000004307 Citrus medica Species 0.000 claims 2
- ODKSFYDXXFIFQN-SCSAIBSYSA-N D-arginine Chemical compound OC(=O)[C@H](N)CCCNC(N)=N ODKSFYDXXFIFQN-SCSAIBSYSA-N 0.000 claims 2
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 claims 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims 2
- 102000014429 Insulin-like growth factor Human genes 0.000 claims 2
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 claims 2
- 102000003982 Parathyroid hormone Human genes 0.000 claims 2
- 108090000445 Parathyroid hormone Proteins 0.000 claims 2
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims 2
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 238000002513 implantation Methods 0.000 claims 2
- 239000000199 parathyroid hormone Substances 0.000 claims 2
- 229960001319 parathyroid hormone Drugs 0.000 claims 2
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims 2
- 108010049974 Bone Morphogenetic Protein 6 Proteins 0.000 claims 1
- 108010049870 Bone Morphogenetic Protein 7 Proteins 0.000 claims 1
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 claims 1
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 claims 1
- 102100022525 Bone morphogenetic protein 6 Human genes 0.000 claims 1
- 102100022544 Bone morphogenetic protein 7 Human genes 0.000 claims 1
- 101710151715 Protein 7 Proteins 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000001002 morphogenetic effect Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9265398P | 1998-07-13 | 1998-07-13 | |
| US13085599P | 1999-04-22 | 1999-04-22 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000559134A Division JP3686335B2 (ja) | 1998-07-13 | 1999-07-12 | 骨および軟骨成長と修復を促進する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005120094A JP2005120094A (ja) | 2005-05-12 |
| JP2005120094A5 true JP2005120094A5 (enExample) | 2006-08-24 |
Family
ID=26785912
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000559134A Expired - Fee Related JP3686335B2 (ja) | 1998-07-13 | 1999-07-12 | 骨および軟骨成長と修復を促進する方法 |
| JP2004304559A Pending JP2005120094A (ja) | 1998-07-13 | 2004-10-19 | 骨および軟骨成長と修復を促進する方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000559134A Expired - Fee Related JP3686335B2 (ja) | 1998-07-13 | 1999-07-12 | 骨および軟骨成長と修復を促進する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6258778B1 (enExample) |
| EP (1) | EP1094829B8 (enExample) |
| JP (2) | JP3686335B2 (enExample) |
| AT (1) | ATE250423T1 (enExample) |
| AU (1) | AU756785B2 (enExample) |
| CA (1) | CA2328871C (enExample) |
| DE (1) | DE69911609T2 (enExample) |
| ES (1) | ES2207258T3 (enExample) |
| WO (1) | WO2000002905A2 (enExample) |
Families Citing this family (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6335195B1 (en) * | 1997-01-28 | 2002-01-01 | Maret Corporation | Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| US20040033950A1 (en) * | 2000-09-26 | 2004-02-19 | Hock Janet M. | Method of increasing bone toughness and stiffness and reducing fractures |
| IL144523A0 (en) * | 1999-02-01 | 2002-05-23 | Genetics Inst | Method and compositions for healing and repair of articular cartilage |
| US6730775B1 (en) | 1999-03-23 | 2004-05-04 | University Of Southern California | Methods for limiting scar and adhesion formation |
| CA2685349C (en) | 1999-11-15 | 2013-09-17 | Bio Syntech Canada Inc. | Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution |
| US6747008B1 (en) | 2000-06-19 | 2004-06-08 | University Of Southern California | Methods for treating and preventing alopecia |
| DK1294414T3 (da) | 2000-06-29 | 2006-07-24 | Biosyntech Canada Inc | Præparat og fremgangsmåde til heling og regenerering af brusk og andre væv |
| US20060094112A1 (en) * | 2001-03-07 | 2006-05-04 | Omotunde Babalola | Biological scaffold |
| DK1395566T3 (da) | 2001-05-31 | 2008-01-07 | Vicore Pharma Ab | Tricycliske forbindelser, der er nyttige som angiotensin Il-agonister |
| WO2003061653A1 (en) * | 2002-01-22 | 2003-07-31 | Pfizer Limited | 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases |
| CA2475953A1 (en) * | 2002-02-27 | 2003-09-04 | E. Ann Tallant | Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth |
| US7957401B2 (en) * | 2002-07-05 | 2011-06-07 | Geos Communications, Inc. | System and method for using multiple communication protocols in memory limited processors |
| JP2006500978A (ja) * | 2002-08-20 | 2006-01-12 | イグザクテック・インコーポレイテッド | 骨成長誘導物質の運搬および送達用組成物、およびその組成物の製造および適用方法 |
| CA2520460A1 (en) * | 2003-03-27 | 2004-10-14 | Children's Hospital Medical Center | Use of fgf- 18 protein, target proteins and their respective encoding nucleotide sequences to induce cartilage formation |
| US7067123B2 (en) | 2003-04-29 | 2006-06-27 | Musculoskeletal Transplant Foundation | Glue for cartilage repair |
| US7488348B2 (en) | 2003-05-16 | 2009-02-10 | Musculoskeletal Transplant Foundation | Cartilage allograft plug |
| US7901457B2 (en) | 2003-05-16 | 2011-03-08 | Musculoskeletal Transplant Foundation | Cartilage allograft plug |
| CN101496917B (zh) | 2003-05-21 | 2013-07-31 | 株式会社Jms | 细胞培养的血清调制装置和血清调制方法及细胞培养方法 |
| US7606217B2 (en) * | 2003-07-02 | 2009-10-20 | I2 Telecom International, Inc. | System and method for routing telephone calls over a voice and data network |
| JP4965251B2 (ja) * | 2003-07-09 | 2012-07-04 | ウォーソー・オーソペディック・インコーポレーテッド | 結合組織成長コンポーネントが豊富に含まれる骨髄画分の単離、及び結合組織の形成を促進するためのその使用 |
| US7399826B1 (en) | 2003-10-02 | 2008-07-15 | Ali Sadat M | Peptide for promoting healing of fractures |
| WO2006020981A2 (en) * | 2004-08-12 | 2006-02-23 | University Of Southern California | Methods for accelerating bone growth and repair |
| US7309589B2 (en) | 2004-08-20 | 2007-12-18 | Vironix Llc | Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing |
| US7837740B2 (en) | 2007-01-24 | 2010-11-23 | Musculoskeletal Transplant Foundation | Two piece cancellous construct for cartilage repair |
| US7815926B2 (en) | 2005-07-11 | 2010-10-19 | Musculoskeletal Transplant Foundation | Implant for articular cartilage repair |
| US8921109B2 (en) | 2005-09-19 | 2014-12-30 | Histogenics Corporation | Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof |
| ATE499120T1 (de) | 2006-05-26 | 2011-03-15 | Baxter Int | Injizierbare fibrin-zusammensetzung zur knochenverstärkung |
| US8658763B2 (en) | 2006-06-20 | 2014-02-25 | Ben-Gurion University Of The Negev Research And Development Authority | Amphiphilic peptides and hydrogel matrices thereof for bone repair |
| EP2117578B1 (en) * | 2007-01-22 | 2015-04-22 | OrthoTrophix, Inc. | A peptide composition and a method of promoting cartilage formation |
| US8435551B2 (en) | 2007-03-06 | 2013-05-07 | Musculoskeletal Transplant Foundation | Cancellous construct with support ring for repair of osteochondral defects |
| ES2573327T3 (es) * | 2007-04-23 | 2016-06-07 | Baxter International Inc. | Composiciones de fibrina que contienen compuestos de estroncio |
| US9457056B2 (en) | 2007-12-04 | 2016-10-04 | Ben-Gurion University Of The Negev Research And Development Authority | Peptides comprising alternating hydrophobic and anionic amino acids for treatment of osteoporosis |
| CA2717725A1 (en) | 2008-03-05 | 2009-09-11 | Musculoskeletal Transplant Foundation | Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
| WO2009114461A2 (en) * | 2008-03-10 | 2009-09-17 | University Of Southern California | Angiotensin (1-7) dosage forms and uses thereof |
| US8808725B2 (en) * | 2008-11-20 | 2014-08-19 | Cartiheal (2009) Ltd. | Solid forms for tissue repair |
| CN102448482A (zh) | 2009-03-27 | 2012-05-09 | 范安德尔研究所 | 甲状旁腺素肽和甲状旁腺素相关蛋白肽及使用方法 |
| RU2408603C1 (ru) * | 2009-07-21 | 2011-01-10 | Ибмед Холдингс Лимитед | Олигопептид, обладающий активностью морфогенетического белка хрящевого происхождения (cdmp-1) по отношению к пролиферации хондроцитов |
| AT508569A1 (de) * | 2009-07-23 | 2011-02-15 | Affiris Ag | Pharmaceutical compound |
| WO2012048298A2 (en) | 2010-10-08 | 2012-04-12 | Caridianbct, Inc. | Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions |
| EP2455388A1 (en) | 2010-11-23 | 2012-05-23 | LanthioPep B.V. | Novel angiotensin type 2 (AT2) receptor agonists and uses thereof. |
| US8454980B2 (en) | 2011-01-26 | 2013-06-04 | Stanley William Whitson | Hydrogel bioscaffold and coating for bone and tooth repair |
| EA026440B1 (ru) | 2011-02-02 | 2017-04-28 | Университи Оф Сатерн Калифорния | Способ лечения диабетической язвы стопы |
| ES2387057B1 (es) | 2011-02-16 | 2013-07-19 | Valeria Lucila Sainz Prestel | Uso de un extracto vegetal como principio activo para la elaboración de un producto con actividad farmacológica para el tratamiento de lesiones tisulares y procedimiento de obtención del extracto |
| WO2013172956A1 (en) | 2012-05-14 | 2013-11-21 | University Of Southern California | Methods for limiting development of a skin wound |
| US8557958B1 (en) | 2012-06-18 | 2013-10-15 | Tarix Pharmaceuticals Ltd. | Compositions and methods for treatment of diabetes |
| WO2014015109A1 (en) * | 2012-07-20 | 2014-01-23 | The Regents Of The University Of California | Methods for producing cartilage and bone |
| US8633158B1 (en) | 2012-10-02 | 2014-01-21 | Tarix Pharmaceuticals Ltd. | Angiotensin in treating brain conditions |
| AU2013342257B2 (en) | 2012-11-08 | 2018-08-30 | Smith & Nephew, Inc. | Improved reattachment of detached cartilage to subchondral bone |
| WO2014074804A2 (en) | 2012-11-08 | 2014-05-15 | Smith & Nephew, Inc. | Methods and compositions suitable for improved reattachment of detached cartilage to subchondral bone |
| EP2968441A1 (en) | 2013-03-15 | 2016-01-20 | University of Southern California | Methods for treating multiple sclerosis |
| EP2967049B1 (en) | 2013-03-15 | 2020-09-02 | University Of Southern California | Methods, compounds, and compositions for the treatment of angiotensin-related diseases |
| AU2014284496A1 (en) | 2013-07-03 | 2016-01-21 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Method for treating cognitive dysfunction |
| WO2015073918A1 (en) | 2013-11-16 | 2015-05-21 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
| US9333233B2 (en) | 2014-02-25 | 2016-05-10 | Tarix Pharmaceuticals Ltd. | Methods and compositions for the delayed treatment of stroke |
| US11008547B2 (en) | 2014-03-25 | 2021-05-18 | Terumo Bct, Inc. | Passive replacement of media |
| CN106456698B (zh) * | 2014-05-19 | 2022-05-17 | 特维娜有限公司 | β-抑制蛋白效应物的合成 |
| US10183055B2 (en) | 2014-07-21 | 2019-01-22 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications |
| CA2955656C (en) | 2014-07-21 | 2023-03-14 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Ang-(1-7) derivative oligopeptides and methods for using and producing the same |
| WO2016049421A1 (en) | 2014-09-26 | 2016-03-31 | Terumo Bct, Inc. | Scheduled feed |
| US10077420B2 (en) | 2014-12-02 | 2018-09-18 | Histogenics Corporation | Cell and tissue culture container |
| WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
| US11965175B2 (en) | 2016-05-25 | 2024-04-23 | Terumo Bct, Inc. | Cell expansion |
| US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
| US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
| US12234441B2 (en) | 2017-03-31 | 2025-02-25 | Terumo Bct, Inc. | Cell expansion |
| US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
| US11629332B2 (en) | 2017-03-31 | 2023-04-18 | Terumo Bct, Inc. | Cell expansion |
| US20220257698A1 (en) | 2019-08-02 | 2022-08-18 | Lanthiopep B.V. | Angiotensin type 2 (at2) receptor agonists for use in the treatment of cancer |
| GB2619893A (en) | 2021-03-23 | 2023-12-20 | Terumo Bct Inc | Cell capture and expansion |
| US12209689B2 (en) | 2022-02-28 | 2025-01-28 | Terumo Kabushiki Kaisha | Multiple-tube pinch valve assembly |
| USD1099116S1 (en) | 2022-09-01 | 2025-10-21 | Terumo Bct, Inc. | Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device |
| WO2025096837A1 (en) * | 2023-10-31 | 2025-05-08 | Life Technologies Corporation | Freeze-dried cell culture media and supplements |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL68218A (en) | 1983-03-23 | 1985-12-31 | Univ Ramot | Compositions for cartilage repair comprising embryonal chondrocytes |
| IL83003A (en) | 1986-07-01 | 1995-07-31 | Genetics Inst | Osteoinductive factors |
| US5013649A (en) | 1986-07-01 | 1991-05-07 | Genetics Institute, Inc. | DNA sequences encoding osteoinductive products |
| US5736372A (en) | 1986-11-20 | 1998-04-07 | Massachusetts Institute Of Technology | Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure |
| US5053050A (en) | 1988-04-29 | 1991-10-01 | Samuel Itay | Compositions for repair of cartilage and bone |
| US5162430A (en) | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
| US5171273A (en) | 1989-01-13 | 1992-12-15 | University Of Medicine And Dentistry Of New Jersey | Synthetic collagen orthopaedic structures such as grafts, tendons and other structures |
| US5015629A (en) | 1989-06-26 | 1991-05-14 | University Of Southern California | Tissue repair |
| US5686116A (en) | 1990-01-12 | 1997-11-11 | New York Society For The Relief Of The Ruptured And Crippled, Maintaining The Hospital For Special Surgery | Methods of enhancing repair, healing and augmentation of bone implants |
| DE69111021T2 (de) | 1990-10-31 | 1996-01-04 | Gendler El | Flexible Membrane hergestellt aus organischer Knochenmatrix zum Ausbessern und Wiederherstellen von Knochen. |
| CA2117379C (en) | 1992-02-14 | 1999-11-16 | Kypriacos A. Athanasiou | Multi-phase bioerodible implant/carrier and method of manufacturing and using same |
| US5589452A (en) | 1992-07-14 | 1996-12-31 | Syntex (U.S.A.) Inc. | Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| PT730465E (pt) | 1993-09-24 | 2002-06-28 | Univ Southern California | Utilizacao de angiotensina iii e de analogos desta em cicatrizacao de tecidos |
| CA2172494A1 (en) | 1993-09-24 | 1995-03-30 | Kathleen Elizabeth Rodgers | Use of angiotensin ii analogs in tissue repair |
| US5955430A (en) | 1993-09-24 | 1999-09-21 | University Of Southern California | Use of angiotensin II fragments and analogs thereof in tissue repair |
| US5443515A (en) | 1994-01-26 | 1995-08-22 | Implex Corporation | Vertebral body prosthetic implant with slidably positionable stabilizing member |
| US5656598A (en) | 1994-03-08 | 1997-08-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Use of fibroblast growth factors to stimulate bone growth |
| US5614515A (en) | 1994-11-17 | 1997-03-25 | University Of Southern California | Lazaroid-based compositions and method for preventing adhesion formation using the same |
| US5834432A (en) | 1995-06-06 | 1998-11-10 | The University Of Southern California | Use of angiotensin II Type 2 receptor agonists in tissue repair |
| CA2223590A1 (en) | 1995-06-07 | 1996-12-19 | The University Of Southern California | Method for reducing or preventing post-surgical adhesion formation using 5-lipoxygenase inhibitors |
| JP3422609B2 (ja) | 1995-11-14 | 2003-06-30 | 花王株式会社 | 使い捨ておむつ |
| US5700774A (en) | 1996-03-26 | 1997-12-23 | Genetics Institute, Inc. | Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same |
| US6110895A (en) | 1996-12-16 | 2000-08-29 | University Of Southern California | Method of promoting healing in skin grafts |
| US6335195B1 (en) | 1997-01-28 | 2002-01-01 | Maret Corporation | Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| AU6650098A (en) | 1997-02-04 | 1998-08-25 | University Of Southern California | Method for accelerating healing of thermal injuries |
| EP1047441A1 (en) | 1997-11-26 | 2000-11-02 | University Of Southern California | Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| US6165978A (en) | 1997-12-12 | 2000-12-26 | University Of Southern California | Wound healing composition |
| US6498138B1 (en) * | 1998-03-11 | 2002-12-24 | University Of Southern California | Method of promoting production of living tissue equivalents |
-
1999
- 1999-07-12 EP EP99933921A patent/EP1094829B8/en not_active Expired - Lifetime
- 1999-07-12 DE DE69911609T patent/DE69911609T2/de not_active Expired - Lifetime
- 1999-07-12 US US09/352,191 patent/US6258778B1/en not_active Expired - Lifetime
- 1999-07-12 JP JP2000559134A patent/JP3686335B2/ja not_active Expired - Fee Related
- 1999-07-12 AT AT99933921T patent/ATE250423T1/de not_active IP Right Cessation
- 1999-07-12 ES ES99933921T patent/ES2207258T3/es not_active Expired - Lifetime
- 1999-07-12 AU AU49869/99A patent/AU756785B2/en not_active Ceased
- 1999-07-12 CA CA002328871A patent/CA2328871C/en not_active Expired - Fee Related
- 1999-07-12 WO PCT/US1999/015735 patent/WO2000002905A2/en not_active Ceased
-
2004
- 2004-10-19 JP JP2004304559A patent/JP2005120094A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005120094A5 (enExample) | ||
| EP0938496B1 (en) | Heptapeptide oxytocin analogues | |
| AU648037B2 (en) | Therapeutic peptides | |
| US20230120030A1 (en) | Long-Acting Adrenomedullin Derivatives | |
| CA2205092A1 (en) | Use of angiotensin ii fragments and analogs thereof in tissue repair | |
| HU217843B (hu) | Paratiroid hormon (PTH) rokon polipeptidek, eljárások ezek előállítására és az ezeket tartalmazó gyógyszerek osteoporosis kezelésére | |
| US20030050436A1 (en) | Octapeptide bombesin analogs | |
| JPH06510046A (ja) | 治療薬の舌下または頬投与のための組成物及び方法 | |
| JP2003535042A (ja) | 鼻腔に投与可能な環式ペプチド組成物 | |
| IL224609A (en) | Intact and peptide intestinal fragments and methods of use | |
| JP2002516872A5 (enExample) | ||
| JPS63154699A (ja) | バソプレシン拮抗剤 | |
| WO1995002610A1 (en) | Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis | |
| JP2004516811A5 (enExample) | ||
| JP2764930B2 (ja) | ペプチドまたはタンパク質の吸収が促進化された医薬組成物 | |
| JPH10501003A (ja) | 免疫調節作用を有する新規ペプチド | |
| EP2408809B1 (fr) | Peptides modulant l'activite de l'igf-1 et leurs applications | |
| JPWO2020097421A5 (enExample) | ||
| US5071836A (en) | Competitive gonadoliberin antagonists | |
| TW386086B (en) | Heptapeptide oxytocin analogues | |
| WO2002009739A1 (en) | Treatment of ocular disorders with somatostatin analogues | |
| WO1995002609A1 (en) | Peptides exhibiting oxytocin antagonistic activity | |
| Coy et al. | Structure—Function of LH-RH Analogs and Design Applications to other Peptide Systems | |
| JPS6072824A (ja) | 代謝疾患治療用医薬製剤 | |
| de la Cruz et al. | When Fujino and co-workers (1972) discovered that [desGly-NH210]-LH-RH ethylamide (pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro |